Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Rohto Pharmaceutical Co Ltd
Unrealized Security Profit/Loss

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rohto Pharmaceutical Co Ltd
Unrealized Security Profit/Loss Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Unrealized Security Profit/Loss CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Unrealized Security Profit/Loss
ÂĄ11.5B
CAGR 3-Years
22%
CAGR 5-Years
15%
CAGR 10-Years
8%
Shiseido Co Ltd
TSE:4911
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kao Corp
TSE:4452
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kose Corp
TSE:4922
Unrealized Security Profit/Loss
ÂĄ4.4B
CAGR 3-Years
-15%
CAGR 5-Years
2%
CAGR 10-Years
17%
F
Fancl Corp
TSE:4921
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Unrealized Security Profit/Loss
ÂĄ13.7B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
10%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
640.7B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Rohto Pharmaceutical Co Ltd's Unrealized Security Profit/Loss?
Unrealized Security Profit/Loss
11.5B JPY

Based on the financial report for Sep 30, 2024, Rohto Pharmaceutical Co Ltd's Unrealized Security Profit/Loss amounts to 11.5B JPY.

What is Rohto Pharmaceutical Co Ltd's Unrealized Security Profit/Loss growth rate?
Unrealized Security Profit/Loss CAGR 10Y
8%

Over the last year, the Unrealized Security Profit/Loss growth was 12%. The average annual Unrealized Security Profit/Loss growth rates for Rohto Pharmaceutical Co Ltd have been 22% over the past three years , 15% over the past five years , and 8% over the past ten years .

Back to Top